Access cutting-edge atopic dermatitis treatment through this phase 2 clinical trial at a research site in South San Francisco. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this South San Francisco location
Preparing your pre-screening questions…
Access atopic dermatitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
Check if you qualify for this atopic dermatitis clinical trial in South San Francisco, CA
No-Cost Study Care
Local to South San Francisco
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their AD changes during the study. The study doctors will see how safe soquelitinib is by tracking side effects among participants. They will also check "tolerability," which means how well the participants can handle soquelitinib and whether any potential side effects are manageable for them. To understand how well soquelitinib works, it will be compared with a placebo. Placebo is a substance that looks like soquelitinib but contains no active medicine in it. Participants will: * Take study treatment (soquelitinib or placebo) every day for 12 weeks * Visit the clinic for check-ups and tests every week for the first 2 weeks then every 2 weeks during the treatment period, and then return for follow-up visits 30, 60, and 90 days after the last dose of study treatment
Sponsor: Corvus Pharmaceuticals, Inc.
Yes, this clinical trial (NCT07441395) has an active research site in South San Francisco, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for atopic dermatitis treatment options in South San Francisco, CA, this clinical trial (NCT07441395) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our South San Francisco research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all atopic dermatitis clinical trials near you to find additional studies recruiting in your area.
See all atopic dermatitis clinical trials recruiting in South San Francisco — not just this study.
Browse Atopic Dermatitis Trials in South San Francisco →